Improve your R&D Strategy with These 6 Tips

Improve your R&D Strategy with These 6 Tips. In 2017, R&D investmentsin the pharmaceutical space reached more than $70 billion, with projected figures of over$200 billion by 2024. Pharma is one of the two sectors with semiconductors that are heavily reinvesting its revenue in research and development (15% to 20% on average). Considering the cost explosion of developing a new drug and bringing it to market, the return on investment is declining sharply, according to aDeloitte 2018 report. The golden days of blockbuster drugs are over. Pharma giants face the challenge of drug patent expirations, which will cut a hefty chunk of revenue, and smaller companies need to spend aggressively to enter highly competitive (and uncertain) markets.Contact UsAs a result, organizations need to rethink their R&D business model to reduce costs and improve efficiency.Pressing Challenges of Today’s Pharmaceutical R&DInnovation on new biological pathways represents a significant investment, with higher risk...